肝癌细胞分泌的外泌体microRNA-103通过靶向连接蛋白增加血管通透性并促进转移
研究发现血清miR-103水平较高与肝细胞癌(HCC)转移潜能较高相关。肝癌细胞通过外泌体将miR-103递送至内皮细胞,直接抑制VE-钙黏蛋白(VE-Cad)、p120-连环蛋白(p120)和闭锁小带蛋白1的表达,削弱内皮连接完整性,增加血管通透性并促进肿瘤细胞跨内皮侵袭和转移。
要点
- 血清miR-103水平较高与HCC转移潜能较高相关。
- 肝癌细胞来源外泌体miR-103可增加内皮单层通透性并促进跨内皮侵袭。
- miR-103通过抑制VE-Cad、p120和闭锁小带蛋白1削弱内皮连接完整性。
核心结论
- 肝癌细胞分泌的外泌体miR-103通过靶向多种内皮连接蛋白增加血管通透性并促进肿瘤转移,提示分泌型miR-103可作为HCC转移的潜在治疗靶点和预测标志物。
研究设计与样本
- 基于深度测序和定量PCR分析血清miR-103与HCC转移潜能的关系,并进行体外内皮通透性实验、跨内皮侵袭实验及小鼠异种移植体内分析。
主要发现
- 血清miR-103水平较高与HCC转移潜能较高相关。
- 高表达miR-103的肝癌细胞条件培养基或外泌体增加内皮单层通透性,而沉默ALIX和HRS阻断外泌体分泌或拮抗肝癌/内皮细胞内的miR-103后该效应减弱。
- 用稳定表达miR-103的肝癌细胞来源外泌体预处理内皮单层促进肿瘤细胞跨内皮侵袭,抑制内皮细胞miR-103后该作用被消除。
- 稳定表达miR-103的肝癌细胞异种移植小鼠较对照小鼠肿瘤血管通透性更高、外泌体miR-103水平更高、血循环中肿瘤细胞数更多,肝和肺转移率增加。
- 肝癌细胞分泌的miR-103经外泌体递送至内皮细胞,直接抑制VE-Cad、p120和闭锁小带蛋白1表达以削弱内皮连接完整性,并可通过抑制肝癌细胞p120表达促进肿瘤细胞迁移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Increased vascular permeability facilitates metastasis. Emerging evidence indicates that secreted microRNAs (miRNAs) may mediate the crosstalk between cancer and stromal cells. To date, whether and how secreted miRNAs affect vascular permeability remains unclear. Based on deep sequencing and quantitative PCR, we found that higher level of serum miR-103 was associated with higher metastasis potential of hepatocellular carcinoma (HCC). The in vitro endothelial permeability and transendothelial invasion assays revealed that the conditioned media or exosomes derived from high miR-103-expressing hepatoma cells increased the permeability of endothelial monolayers, but this effect was attenuated if exosome secretion of hepatoma cells was blocked by silencing ALIX and HRS or if miR-103 within hepatoma or endothelial cells was antagonized. Most importantly, pretreating endothelial monolayers with exosomes that were from stable miR-103-expressing hepatoma cells facilitated the transendothelial invasion of tumor cells, and this role of exosomes was abrogated by inhibiting miR-103 in endothelial cells. Further in vivo analyses disclosed that mice with xenografts of stable miR-103-expressing hepatoma cells exhibited higher vascular permeability in tumor, higher level of exosomal miR-103 and greater number of tumor cells in blood circulation, and increased rates of hepatic and pulmonary metastases, compared to control mice. Mechanism investigations revealed that hepatoma cell-secreted miR-103 could be delivered into endothelial cells via exosomes, and then attenuated the endothelial junction integrity by directly inhibiting the expression of VE-Cadherin (VE-Cad), p120-catenin (p120) and zonula occludens 1. Moreover, miR-103 could also promote tumor cell migration by repressing p120 expression in hepatoma cells. CONCLUSION: Hepatoma cell-secreted exosomal miR-103 increases vascular permeability and promotes tumor metastasis by targeting multiple endothelial junction proteins, which highlights secreted miR-103 as a potential therapeutic target and a predictive marker for HCC metastasis. (Hepatology 2018).
引用
- Fang JH, Zhang ZJ, Shang LR, et al. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins. Hepatology. 2018. PMID: 29637568. doi:10.1002/hep.29920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。